OBJECTIVE: The purpose of this study was to evaluate the test-retest reliability of the Timeline Followback (TLFB) interview for assessing daily alcohol and drug use with adults living with a severe mental illness. METHOD: Participants were 132 psychiatric outpatients (64% men) with a confirmed schizophrenia-spectrum (52%) or major mood disorder (48%) and a lifetime history of substance use disorder. They completed a 90-day TLFB twice, separated by a mean of 5 days, and represented 55% of the participants who originally consented to be in the study. RESULTS: Test-retest reliability coefficients ranged from 0.73 to 1.00 (rounded) for 30-day TLFB and from 0.77 to 1.00 (rounded) for the 90-day TLFB. Within-subject comparisons of means across the three 30-day windows revealed no significant differences, and no degradation of the magnitude of the reliability coefficients was observed with increasingly distant assessment periods. CONCLUSIONS: The TLFB is a reliable method of assessing alcohol and drug use in outpatients diagnosed with severe mental illness.
OBJECTIVE: The purpose of this study was to evaluate the test-retest reliability of the Timeline Followback (TLFB) interview for assessing daily alcohol and drug use with adults living with a severe mental illness. METHOD:Participants were 132 psychiatric outpatients (64% men) with a confirmed schizophrenia-spectrum (52%) or major mood disorder (48%) and a lifetime history of substance use disorder. They completed a 90-day TLFB twice, separated by a mean of 5 days, and represented 55% of the participants who originally consented to be in the study. RESULTS: Test-retest reliability coefficients ranged from 0.73 to 1.00 (rounded) for 30-day TLFB and from 0.77 to 1.00 (rounded) for the 90-day TLFB. Within-subject comparisons of means across the three 30-day windows revealed no significant differences, and no degradation of the magnitude of the reliability coefficients was observed with increasingly distant assessment periods. CONCLUSIONS: The TLFB is a reliable method of assessing alcohol and drug use in outpatients diagnosed with severe mental illness.
Authors: Jo Ann Y Sacks; Robert E Drake; Valerie F Williams; Steven M Banks; James M Herrell Journal: J Nerv Ment Dis Date: 2003-03 Impact factor: 2.254
Authors: Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman Journal: Schizophr Bull Date: 2012-01-26 Impact factor: 9.306
Authors: Jon Morgenstern; Alexis N Kuerbis; Andrew C Chen; Christopher W Kahler; Donald A Bux; Henry R Kranzler Journal: J Consult Clin Psychol Date: 2012-05-21
Authors: Meghan E McDevitt-Murphy; James G Murphy; Joah L Williams; Christopher J Monahan; Katherine L Bracken-Minor; Jordan A Fields Journal: J Consult Clin Psychol Date: 2014-04-28
Authors: Tyler B Wray; Alexander C Adia; Ashley E Pérez; Erik M Simpanen; Laura-Allison Woods; Mark A Celio; Peter M Monti Journal: Am J Drug Alcohol Abuse Date: 2018-05-14 Impact factor: 3.829
Authors: Katherine E Watkins; Alison E Cuellar; Kimberly A Hepner; Sarah B Hunter; Susan M Paddock; Brett A Ewing; Erin de la Cruz Journal: J Subst Abuse Treat Date: 2013-10-02
Authors: David A Fiellin; Kathleen A McGinnis; Stephen A Maisto; Amy C Justice; Kendall Bryant Journal: J Stud Alcohol Drugs Date: 2013-05 Impact factor: 2.582